Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...
After losing his grandmother to cancer at just seven years old, Calipher Harewood became determined to do what he could to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback